سعر جينيبرال 10 مكجم/2 مل 5 أمبولات 2022

Gynipral injection (Arab Drug Company): 5 ampoules of 2 ml, each containing hexoprenaline 10 micrograms; a beta-2 sympathomimetic used internationally for acute tocolysis.

• Short-term treatment of uncomplicated preterm labour: inhibition of labour between the 22nd and 37th week of pregnancy in patients without medical or obstetric contraindications to tocolysis.BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)
• Before version (turning) of a transverse lie, and as an emergency measure in preterm labour outside hospital before transfer to hospital.BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)

• Very common: muscle tremor, tachycardia. Common: hypokalaemia, palpitations, decreased diastolic blood pressure, hypotension, sweating. Uncommon: pulmonary oedema. Rare: hyperglycaemia, cardiac arrhythmias (e.g. atrial fibrillation), myocardial ischaemia, peripheral vasodilatation, nausea. Frequency not known: headache, dizziness, restlessness, vomiting, reduced bowel motility, transient transaminase rise, reduced urine output.International label, same formulation · BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)

• Hypersensitivity to the active substance or excipients; any condition at a gestational age below 22 weeks; pre-existing ischaemic heart disease or significant risk factors for it (as a tocolytic); threatened abortion in the 1st/2nd trimester; any maternal or fetal condition in which prolonging pregnancy is hazardous (e.g. severe toxaemia, intrauterine infection, vaginal bleeding from placenta praevia, eclampsia or severe pre-eclampsia, placental abruption, cord compression); intrauterine fetal death or known lethal congenital/chromosomal malformation.International label, same formulation · BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)
• Heart disease, especially tachyarrhythmias, myocarditis and mitral valve disease; pulmonary hypertension, hypertrophic obstructive cardiomyopathy or any left-ventricular outflow obstruction (e.g. aortic stenosis); hyperthyroidism; severe hepatic or renal disease; angle-closure glaucoma; sulfite-sensitive bronchial asthma.International label, same formulation · BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)

• Contains sodium metabisulfite, which can rarely cause severe hypersensitivity reactions and bronchospasm.International label, same formulation · BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)
• Pulmonary oedema and myocardial ischaemia may occur during and after beta-agonist tocolysis; monitor fluid balance and cardiorespiratory function closely (higher risk with multiple pregnancy, hypervolaemia, maternal infection, pre-eclampsia and concomitant corticosteroids) and stop treatment if symptoms of myocardial ischaemia occur.International label, same formulation · BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)

• Halogenated inhalational anaesthetics (e.g. halothane)Additive hypotensive effect with uterine atony and bleeding risk, and serious ventricular arrhythmias reported; stop treatment at least 6 hours before planned anaesthesia with halogenated anaesthetics where possible.BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)
• CorticosteroidsConcomitant use increases the risk of pulmonary oedema, hyperglycaemia and hypokalaemia; close monitoring required.BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)
• Antidiabetic medicinesHexoprenaline can raise blood glucose and reduce the effect of antidiabetic treatment.BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)

• This medicine is intended for use during pregnancy (see indications).International label, same formulation · BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)
• No data, because use during breast-feeding is not intended.International label, same formulation · BASG Arzneispezialitätenregister (Austrian Federal Office for Safety in Health Care)

• Hexoprenaline: Stimulates beta-2 adrenergic receptors, relaxing uterine (and bronchial) smooth muscle.